Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other Non-Current Assets (2020 - 2025)

Arcutis Biotherapeutics has reported Other Non-Current Assets over the past 6 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $1.4 million for Q4 2025, up 129.98% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (up 129.98% YoY), and the annual figure for FY2025 was $1.4 million, up 129.98%.
  • Other Non-Current Assets for Q4 2025 was $1.4 million at Arcutis Biotherapeutics, up from $300000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ARQT hit a ceiling of $1.4 million in Q4 2025 and a floor of $78000.0 in Q1 2021.
  • Median Other Non-Current Assets over the past 5 years was $608500.0 (2024), compared with a mean of $636300.0.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 94.94% in 2021 and later skyrocketed 1482.05% in 2022.
  • Arcutis Biotherapeutics' Other Non-Current Assets stood at $78000.0 in 2021, then skyrocketed by 1482.05% to $1.2 million in 2022, then dropped by 27.07% to $900000.0 in 2023, then crashed by 31.44% to $617000.0 in 2024, then soared by 129.98% to $1.4 million in 2025.
  • The last three reported values for Other Non-Current Assets were $1.4 million (Q4 2025), $300000.0 (Q3 2025), and $300000.0 (Q2 2025) per Business Quant data.